Express Scripts (ESRX) was upgraded by Citigroup (C) to neutral from buy with a price target of $ 62, as the current stock price provides an attractive entry point based on valuation for investors. Shares are higher by over 2.3 percent.
See all stories on this topic »
Google Alerts – intitle:gps -intext:Gap -intext:GP -intext:health -intext:doctor
Note: Newswire stories are provided as a courtesy of Rated4Stars.com. Content of these articles is provided by external sources.
Speak Your Mind
You must be logged in to post a comment.